Amneal reports fourth quarter and full year 2023 financial results

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nasdaq: amrx) (“amneal” or the “company”) today announced its results for the fourth quarter and full year ended december 31, 2023. “amneal had a very successful year in 2023 as we delivered strong execution and growth across our diversified pharmaceutical business. we are starting 2024 with substantial momentum and key catalysts, including complex high-value products, biosimilars and specialty, to further expand our reach. again.
AMRX Ratings Summary
AMRX Quant Ranking